BTQ Technologies heads into July with a striking disconnect: borrow costs have more than doubled in a month while short interest itself remains negligible, pointing to something more structural happening in the lending market than a conventional bear thesis.
The most compelling story this week is not the short position — it is what it costs to maintain one. Cost to borrow has nearly doubled since late May, climbing from roughly 9.5% to a peak of 28.2% mid-week before easing slightly to 21.4% by June 30. That 116% rise over the past month is sharp for a stock where the short position covers less than 1% of the free float. Availability is tightening in parallel: the lending pool now has only about one share available for every five already borrowed (availability at 20%), down sharply from 33% just eight days ago and well below the 52-week high of 99.6%. The 52-week low on availability was 1.4%, a reminder that the pool can compress further. Short shares outstanding have actually been drifting lower, dropping from roughly 1.16 million in early June to 1.08 million now, so rising borrow costs are not being driven by new short demand — they reflect supply tightening in the lending market for a thinly traded small-cap.
The ORTEX short score captures the overall picture neatly. It has been climbing steadily, from 51.3 two weeks ago to 54.7 now, registering a more charged lending environment even as the outright short position remains low. Days-to-cover is a notable 5.1 on the official FINRA data, elevated for a stock this lightly shorted, which flags how illiquid the real borrow pool has become. Factor ranks confirm the lean: the DTC rank and utilization rank both sit at just the 8th percentile, placing BTQ among the more constrained names in the universe on these metrics despite the low headline short interest.
On the stock itself, BTQ fell 8.5% on the week to CAD 7.64, pulling back after a strong month that had delivered a 12% gain. The recent note history flags the fundamental picture: growth scores near the bottom of the universe (a 93% year-on-year sales decline, Piotroski F-score of 2), while the only pillar holding up is near-term momentum. Peer performance was mixed — ARQQ rose 2.3% on the week and INTZ surged 31%, while QBTS fell 4.2% and AISP dropped 14.6%. BTQ's decline sits in the middle of that dispersed peer group, reflecting the volatility typical of early-stage quantum and cybersecurity names. Valuation data is stale (enterprise value was marked at roughly $974 million as of December 2025) and no fresh analyst coverage is available for this NEOE-listed name — both facts that underscore how thinly covered and sentiment-driven this stock remains.
Insider activity is the one data point worth watching for fundamental signal. CEO and Founder Olivier Roussy Newton made three open-market purchases in late 2025 and January 2026, picking up 300,000 shares across a price range of roughly CAD 5 to CAD 7.50 — a commitment totalling around CAD $1.3 million in local currency terms. More recently, a senior officer sold 1,250 shares in June at CAD 4.78, a token disposal that does not change the broader picture of management accumulation. The CEO buying has not been followed by fresh purchases at current levels, which at CAD 7.64 now sit above most of his entry points.
Next earnings are scheduled for August 13. Given that the last four reporting events produced a wide range of outcomes — a 1-day move of +18% on May 22, alongside prior single-day drops of 7–9% — the August print will be the next hard test of whether the momentum pillar that has kept BTQ's score afloat can find support from any improvement on the fundamental side. Until then, the key readings to track are whether borrow availability continues tightening toward its 52-week low, and whether the CEO steps back in with fresh open-market purchases at current prices.
See the live data behind this article on ORTEX.
Open BTQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
